Abstract
Sézary syndrome is a rare type of cutaneous T-cell lymphoma with poor prognosis and characterized by erythroderma and leukemic involvement. Correlation with molecular and flow cytometric studies is essential for the diagnosis. The differential diagnosis includes benign causes of erythroderma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Elder DE, Massi D, Scolyer RA, Willemze R, editors. WHO classification of skin tumors. 4th ed. Lyon: IARC; 2018.
Kubica AW, Pittelkow MR. Sézary syndrome. Surg Pathol Clin. 2014;7(2):191–202.
Kubica AW, Davis MD, Weaver AL, Killian JM, Pittelkow MR. Sézary syndrome: a study of 176 patients at Mayo Clinic. J Am Acad Dermatol. 2012;67(6):1189–99.
Swerdlow SH, et al., editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: IARC; 2008.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th ed). Lyon: IARC; 2017.
Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–85.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Subtil, A. (2019). Sézary Syndrome. In: Diagnosis of Cutaneous Lymphoid Infiltrates. Springer, Cham. https://doi.org/10.1007/978-3-030-11654-5_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-11654-5_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11652-1
Online ISBN: 978-3-030-11654-5
eBook Packages: MedicineMedicine (R0)